1800-272-662
Shopping Cart 0
countryflagAU
Login

Indiva Ltd

Healthcare CA NDVA

NoneCAD
-(-%)

Last update at 2024-09-25T03:34:09.773072Z

Day Range

--
LowHigh

52 Week Range

0.010.12
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap19.56M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.34855M
  • Revenue TTM36.01M
  • Revenue Per Share TTM0.23
  • Gross Profit TTM 8.15M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -11.05035M -15.27619M -15.42157M -11.39789M -8.65609M
Minority interest - - - - -
Net income -10.93205M -15.00923M -15.42263M -11.39789M -8.52663M
Selling general administrative 12.82M 11.50M 7.47M 9.08M 7.35M
Selling and marketing expenses - - - - -
Gross profit 8.15M 7.07M -0.87355M 0.05M 0.10M
Reconciled depreciation 0.41M 0.49M 0.39M 0.86M 0.41M
Ebit -6.09802M -5.54697M -8.88625M -9.54474M -7.65093M
Ebitda -6.19428M -11.85770M -13.29102M -10.09550M -7.08479M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -6.09802M -6.44230M -11.53268M -10.09695M -7.65093M
Other operating expenses - - - 0.24M 0.24M
Interest expense 4.45M 2.93M 2.02M 0.44M 1.16M
Tax provision -0.11830M -0.26695M 0.00106M 0.00000M -0.12946M
Interest income 0.04M 0.22M 0.00001M 0.14M 0.11M
Net interest income -4.68185M -2.71514M -2.02047M -0.30221M -1.05134M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.11830M -0.26695M 0.00106M - -0.12946M
Total revenue 34.40M 32.47M 14.65M 0.92M 0.06M
Total operating expenses 40.50M 38.91M 26.18M 11.02M 7.71M
Cost of revenue 26.25M 25.40M 15.52M 0.87M -0.04314M
Total other income expense net -0.27048M -6.11875M -1.86842M -0.99874M 0.05M
Discontinued operations - - - - -
Net income from continuing ops -10.93205M -15.00923M -15.42263M -11.39789M -8.52663M
Net income applicable to common shares -10.93205M -15.21666M -15.42263M -11.39789M -8.52663M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 37.85M 42.44M 39.17M 38.10M 35.85M
Intangible assets 1.66M 1.87M 2.08M 0.00903M 0.35M
Earning assets - - - - -
Other current assets 0.44M 0.38M 0.29M 0.04M 0.61M
Total liab 35.70M 30.11M 27.95M 18.81M 6.45M
Total stockholder equity 2.15M 12.33M 11.22M 19.29M 29.40M
Deferred long term liab - - - - -
Other current liab 0.43M 0.05M 5.10M 1.41M 1.02M
Common stock 57.39M 57.23M 42.42M 37.49M 37.28M
Capital stock 57.39M 57.23M 42.42M 37.49M 37.28M
Retained earnings -67.47958M -56.54753M -41.23681M -25.81418M -14.41629M
Other liab 0.72M 0.73M 0.76M - -
Good will - - - - -
Other assets 1.97M 2.60M 2.17M 3.35M 2.79M
Cash 2.79M 2.48M 0.31M 0.63M 19.57M
Cash and equivalents - - - - -
Total current liabilities 13.38M 8.89M 24.03M 16.54M 6.45M
Current deferred revenue - - - - -
Net debt 18.66M 18.45M 11.83M 7.06M -
Short term debt - - - - 4.40M
Short long term debt 0.25M 0.70M 9.70M 6.23M 4.40M
Short long term debt total - - - - -
Other stockholder equity 6.23M 5.61M 5.32M 7.22M 6.53M
Property plant equipment 22.54M 22.46M 22.69M 22.47M 9.28M
Total current assets 11.68M 15.51M 12.22M 10.51M 22.07M
Long term investments - 0.00000M 0.00000M 1.77M 3.31M
Net tangible assets 0.49M 10.16M 9.14M 19.28M 29.05M
Short term investments - - - - 0.00000M
Net receivables 4.13M 5.87M 4.73M 0.83M 0.60M
Long term debt 21.20M 20.23M 2.44M 1.46M -
Inventory 4.14M 6.44M 6.57M 8.80M 1.16M
Accounts payable 12.22M 7.83M 7.25M 8.58M 1.89M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 27.59M 12.94M
Deferred long term asset charges - - - - -
Non current assets total 26.17M 26.93M 26.95M 27.59M 12.94M
Capital lease obligations 0.56M 0.71M 1.36M 0.92M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.02909M -1.79111M -2.08163M -0.88742M -1.22139M
Change to liabilities 4.45M -1.17689M 2.38M 6.94M 0.76M
Total cashflows from investing activities -1.02909M -1.79111M -2.08163M -12.20414M -5.10013M
Net borrowings -0.21516M 6.27M 3.89M 3.20M 3.20M
Total cash from financing activities -0.21516M 21.80M 8.75M 3.20M 12.90M
Change to operating activities 0.38M -6.09297M -0.18416M -0.20499M -2.38110M
Net income -10.93205M -15.21666M -15.42263M -11.39789M -8.52663M
Change in cash 0.31M 2.17M -0.31706M -18.93450M -1.73828M
Begin period cash flow 2.48M 0.31M 0.63M 19.57M 21.30M
End period cash flow 2.79M 2.48M 0.31M 0.63M 19.57M
Total cash from operating activities 1.55M -17.84252M -6.98073M -9.92991M -9.53725M
Issuance of capital stock 0.00000M 15.26M 4.98M - -
Depreciation 0.41M 0.49M 0.39M 0.63M 0.41M
Other cashflows from investing activities 0.04M 0.00470M 0.00001M -0.16267M 0.11M
Dividends paid - - - 0.00000M 0.00000M
Change to inventory 1.22M -1.53330M 0.80M -7.58690M -0.97043M
Change to account receivables 1.73M -1.15151M -4.13769M -0.44006M -0.44006M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - -0.32487M -0.75071M -2.09071M
Change to netincome 3.31M 5.81M 7.31M 1.22M 1.58M
Capital expenditures 1.07M 1.80M 2.32M 12.06M 3.71M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 7.79M -9.95466M 0.13M -0.35279M -3.18642M
Stock based compensation 0.75M 0.53M 0.25M 0.81M -
Other non cash items 1.22M 2.50M 0.71M -0.63311M 1.05M
Free cash flow 0.48M -19.63834M -9.30046M -20.70797M -13.52987M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NDVA
Indiva Ltd		 - -% - - 14.49 0.54 52.69 1.04 -19.2904
RX
Biosyent Inc.		 -0.06 0.39% 15.50 16.87 14.43 3.74 3.54 2.82 9.35
LSL
LSL Pharma Group Inc.		 -0.01 2.41% 0.41 25.50 - 2.31 2.48 3.41 12.21
DB
Decibel Cannabis Company Inc		 0.005 4.00% 0.13 3.17 5.43 0.50 0.86 0.86 4.57
ZYUS
ZYUS Life Sciences Corporation		 - -% 0.60 - - 111.93 4.41 145.46 -4.258

Reports Covered

Stock Research & News

View All

Profile

Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.

Indiva Ltd

333 Preston Street, Ottawa, ON, Canada, K1S 5N4

Key Executives

Name Title Year Born
Mr. Carmine Marotta Co-Founder, Pres, CEO & Director NA
Ms. Jennifer Welsh Chief Financial Officer NA
Mr. Robert William Carse Chief Operating Officer NA
Mr. Dave Paterson Chief Commercial Officer NA
Mr. Pete Young Co-founder NA
Ms. Kate Abernathy VP of Communications NA
Ms. Sherry Kelly Director of Human Resource NA
Mr. Tomasz Borowicz Chief Brand Officer NA
Ms. Leah Thiel Marketing Director NA
Mr. Eric Van Dam Sales Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.